Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1989
Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative Group
J P Neijt, M E van der Burg, J P Guastalla, et al.
Minerva Chirurgica
|
September 30, 1988
[Radical surgery in carcinoma of the breast]
C Mossetti, C Monzeglio, F Carnino, et al.
The Journal of Clinical Investigation
|
February 1, 1989
Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor
M Aglietta, W Piacibello, F Sanavio, et al.
Tumori
|
April 30, 1988
Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot study
P F Conte, M Bruzzone, S Chiara, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
October 1, 1987
Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma
S Chiara, P F Conte, M Bruzzone, et al.
Minerva Ginecologica
|
April 1, 1984
[Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group]
P F Conte, R Rosso, M Bruzzone, et al.
International Journal of Cancer
|
October 15, 1987
Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic results
P F Conte, A Alama, G Bertelli, et al.
Breast Cancer Research and Treatment
|
May 19, 2000
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
A Michelotti, M Venturini, C Tibaldi, et al.
Anticancer Research
|
September 1, 1995
Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study
L Del Mastro, M Venturini, P G Giannessi, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1988
Esorubicin in advanced ovarian epithelial cancer. A phase II study of the EORTC Gynecological Cancer Cooperative Group
A T van Oosterom, M S Aapro, F Carnino, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1989
Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative Group
J P Neijt, M E van der Burg, J P Guastalla, et al.
Minerva Chirurgica
|
September 30, 1988
[Radical surgery in carcinoma of the breast]
C Mossetti, C Monzeglio, F Carnino, et al.
The Journal of Clinical Investigation
|
February 1, 1989
Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor
M Aglietta, W Piacibello, F Sanavio, et al.
Tumori
|
April 30, 1988
Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot study
P F Conte, M Bruzzone, S Chiara, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
October 1, 1987
Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma
S Chiara, P F Conte, M Bruzzone, et al.
Minerva Ginecologica
|
April 1, 1984
[Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group]
P F Conte, R Rosso, M Bruzzone, et al.
International Journal of Cancer
|
October 15, 1987
Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic results
P F Conte, A Alama, G Bertelli, et al.
Breast Cancer Research and Treatment
|
May 19, 2000
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
A Michelotti, M Venturini, C Tibaldi, et al.
Anticancer Research
|
September 1, 1995
Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study
L Del Mastro, M Venturini, P G Giannessi, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1988
Esorubicin in advanced ovarian epithelial cancer. A phase II study of the EORTC Gynecological Cancer Cooperative Group
A T van Oosterom, M S Aapro, F Carnino, et al.
Page
of 5